CD44 N‐Glycosylation Alleviates Myocardial Ischemia–Reperfusion Through PI3K/AKT/mTOR Pathway
Cell Biology International · 2026
DOI: 10.1002/cbin.70132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2026. Verfasst von Yanxin Ren und 11 weiteren Autor:innen. Beteiligte Einrichtung: The 2nd Medical College of Binzhou Medical University, Yantai, Shandong, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Hyaluronan Receptors, Phosphatidylinositol 3-Kinases. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Myocardial ischemia–reperfusion injury (MIRI) is one of the leading causes of morbidity and mortality from cardiovascular diseases worldwide. Protein N‐glycosylation plays an important role in MIRI. However, there is limited knowledge regarding N‐glycoproteins in MIRI and their alterations during MIRI. This study aims to investigate the dynamic changes of N‐glycosylation modification in MIRI and the regulatory mechanisms of key proteins in MIRI to provide new therapeutic targets for the clinical diagnosis and treatment of MIRI. This study systematically explored the dynamic changes of N‐glycosylation modification in MIRI through an integrated glycoproteomic analysis, combining a clinical sample, animal models, and cell models. Differential glycoproteins were identified using quantitative N‐glycoproteomic mass spectrometry. Key regulatory molecules were screened through GO functional annotation and KEGG pathway enrichment. The integrated analysis identified 698 N‐glycosylated proteins. Pathway enrichment analysis showed that the differentially expressed proteins were mainly involved in the PI3K/AKT/mTOR signaling pathway. The study of differentially expressed N‐glycoproteins revealed that CD44 was upregulated and could regulate AKT. One possible reason is that N‐glycosylation of CD44 affects its stability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The 2nd Medical College of Binzhou Medical University, Yantai, Shandong, China.
- Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong, China.
- Qingdao Medical College, Qingdao University, Qingdao, Shandong, China.
- Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Otolaryngology-Head and Neck Surgery, Lanzhou University Second Hospital, Lanzhou, Gansu, P. R. China.
ORCID-Profile: Jikai Song, Jun Yang, Wenjuan Jia
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Ren, Y., Dong, H., Huang, Q., Xu, B., Fu, K., Song, J., Gong, L., Wang, Y., Ding, X., Zhong, L., Yang, J., & Jia, W. (2026). CD44 N‐Glycosylation Alleviates Myocardial Ischemia–Reperfusion Through PI3K/AKT/mTOR Pathway. Cell Biology International. https://doi.org/10.1002/cbin.70132
Vancouver
Ren Y, Dong H, Huang Q, Xu B, Fu K, Song J, et al. CD44 N‐Glycosylation Alleviates Myocardial Ischemia–Reperfusion Through PI3K/AKT/mTOR Pathway. Cell Biology International. 2026. doi:10.1002/cbin.70132
BibTeX
@article{Ren2026,
author = {Ren, Yanxin and Dong, Haibin and Huang, Qingwen and Xu, Bowen and Fu, Kaixuan and Song, Jikai and Gong, Lei and Wang, Yiming and Ding, Xiaoning and Zhong, Lin and Yang, Jun and Jia, Wenjuan},
title = {CD44 N‐Glycosylation Alleviates Myocardial Ischemia–Reperfusion Through PI3K/AKT/mTOR Pathway},
journal = {Cell Biology International},
year = {2026},
doi = {10.1002/cbin.70132}
}
EUVIMED